Stem Cell Therapy News Now Available on Twitter

Dusseldorf, Germany (PRWEB) January 28, 2010

The XCell-Center announces the official launch of its stem cell therapy news campaign on Twitter.com to meet the demand of prospective and treated patients who wish to receive real-time updates on treatment success stories, newly available treatments and other newsworthy events.

To start receiving updates today, please visit http://twitter.com/xcellcenter

Since treating its first patient in early 2007, the XCell-Center has emerged as Europe’s leading stem cell therapy provider. In December 2009, the XCell-Center attained ISO 9001 quality management certification. By implementing ISO standards, the XCell-Center demonstrates its commitment to excellence in safety and quality for the benefit of its patients.

Patients from all over the world visit the XCell-Center seeking treatment for spinal cord injury, diabetes, cerebral palsy, heart disease, autism, various eye diseases and other neurological disorders like stroke and Parkinson’s. Many of them have experienced remarkable improvements following treatment.

“Jannat was in very poor condition… Now, one year after her treatment, Jannat can speak clearly and fluently. … She is even able to stand with the aid of a support. …Today, we are once again in Düsseldorf to get a second treatment for our daughter because what we observed after the first treatment, gave us the hope for even greater improvement,” commented the parents of Jannat Abu Kaf, a five year-old Israeli cerebral palsy patient who was first treated in December, 2008.

The treatment process consists of three steps: bone marrow collection, laboratory processing and stem cell implantation.

Bone Marrow Collection
On the first day, bone marrow is collected from the patient’s iliac crest (hip bone) using thin-needle mini-puncture under local or general anesthesia (mainly in children). The entire procedure normally takes about 30 minutes. Each patient is treated with his or her own stem cells.

Laboratory Processing
The next day, the stem cells are processed from the bone marrow in a state-of-the-art, government approved (cGMP) laboratory. In the lab, both the quantity and quality of the stem cells are measured by sophisticated, analytical instruments.

Stem Cell Implantation
On the third day, the stem cells are implanted using a variety of methods, each designed to optimize placement of the cells as safely and closely as possible to the damaged organ or tissue.

Lumbar Puncture – Stem cells are injected into the spinal fluid under local or general anesthesia to treat neurological diseases/disorders in the brain and the spinal cord.

Surgical Implantation – Stem cells are implanted directly into the brain under general anesthesia using MRI/PET/CT mapping and a high tech navigation system allowing the cells to be placed with the highest accuracy while minimizing the risks.

Neuro-endoscopic Autologous Stem Cell Implantation (NEASCI™) – Stem cells are implanted under general anesthesia into the cerebral fluid space(s) using a mini-endoscope and catheter with MRI/PET/CT mapping.

Angiography – Stem cells are implanted into the pancreatic artery for diabetes or the coronary arteries for heart disease using a fine wire (catheter) under local anesthesia.

Direct Injection – Stem cells are injected directly into the target tissue such as leg muscles for neuropathy or the joint(s) for arthritis.

Intravenous Injection – When other implantation methods are not possible due to safety considerations or the damage is diffuse, the stem cells can be injected into the bloodstream intravenously.

“...At the year mark, I look back and feel truly blessed at the progress she has made… Her frustration level went from about 75% to 10%. Her hyperactivity probably 99% to 20%... Her cognitive abilities have greatly improved. I think she is the teacher’s pet this year. Never been able to say that before!...,” noted Judy DiCorcia, the mother of an 11 year-old girl who was first treated at the XCell-Center for Autism in January, 2009.

Patients who are interested in stem cell therapy at the XCell-Center can start by completing the Medical Information Form online: http://www.xcell-center.com/request-information.aspx

About the XCell-Center
The XCell-Center operates treatment centers in Cologne and Dusseldorf, Germany. It is the first privately-owned clinic in Europe to specialize in regenerative medicine using autologous bone marrow stem cell therapy and operates in accordance with German law and European guidelines. Its specialized medical team of German physicians includes specialists in: neurosurgery, orthopedics, cardiology, radiology, anesthesiology and pharmacology.

The XCell-Center also treats Diabetes and its complications (Erectile Dysfunction and Peripheral Artery Disease), Stroke, Cerebral Palsy, Autism, Spinal Cord Injuries, Orthopedic diseases, Heart Disease and degenerative diseases such as Multiple Sclerosis, Parkinson's, Alzheimer's and several eye diseases.

For more information on Stem Cell Therapy:

XCell-Center Website: http://www.xcell-center.com

XCell-Center GmbH
at the Institute for Regenerative Medicine
Am Heerdter Krankenhaus 2
40549 Dusseldorf, Germamy

Phone: 1-866-680-8202 (USA Toll-Free)
(+49) 0221-802-5095 (Germany)
Fax:        1-713-583-9322 (USA)                
(+49) 0221-2921-2550 (Germany)

###